GE to Continue to Grow MegaBACE Following Amersham Acquisition; Biosciences Assets Have Bright Future | GenomeWeb

This update serves to clarify Trevor Hawkins' title. He is senior vice president of development and new business initiatives in the discovery systems business, not vice president of business development.

NEW YORK, April 8 (GenomeWeb News) - GE will continue to support the genomics technologies that were developed under the discovery systems and protein-separations flags of Amersham Biosciences, a top GE official told GenomeWeb News today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.